Alcon Net Income 2019-2022 | ALC

Alcon annual/quarterly net income history and growth rate from 2019 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Alcon net income for the quarter ending September 30, 2022 was $0.116B, a 5700% increase year-over-year.
  • Alcon net income for the twelve months ending September 30, 2022 was $571M, a 71.99% increase year-over-year.
  • Alcon annual net income for 2021 was $0.376B, a 170.81% decline from 2020.
  • Alcon annual net income for 2020 was $-0.531B, a 19.05% decline from 2019.
  • Alcon annual net income for 2019 was $-0.656B, a 188.99% increase from 2018.
Alcon Annual Net Income
(Millions of US $)
2021 $376
2020 $-531
2019 $-656
2018 $-227
Alcon Quarterly Net Income
(Millions of US $)
2022-09-30 $116
2022-06-30 $148
2022-03-31 $168
2021-12-31 $139
2021-09-30 $2
2021-06-30 $151
2021-03-31 $84
2020-12-31 $95
2020-09-30 $-147
2020-06-30 $-422
2020-03-31 $-57
2019-12-31 $-91
2019-09-30 $-66
2019-06-30 $-390
2019-03-31 $-109
2018-12-31
2018-09-30 $-207
2018-06-30 $15
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $37.369B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00